Vol 10, Supplement 2 (January 30, 2018): Journal of Thoracic Disease (Present and Future of the Malignant Pleural Mesothelioma)

Preface

The everlasting story of malignant pleural mesothelioma: where do we stand?
Marco Lucchi, Alfredo Mussi, Luca Bertolaccini, Roberto Crisci
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S192-S193
.

Original Article

Physicochemical and pharmacokinetic properties of polymeric films loaded with cisplatin for the treatment of malignant pleural mesothelioma
Fabio Sonvico, Stefano Barbieri, Paolo Colombo, Claudio Mucchino, Elisabetta Barocelli, Anna Maria Cantoni, Andrea Cavazzoni, Pier Giorgio Petronini, Michele Rusca, Paolo Carbognani, Luca Ampollini
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S194-S206
.
Polymeric films loaded with cisplatin for malignant pleural mesothelioma: a pharmacokinetic study in an ovine model
Luca Ampollini, Elisabetta Barocelli, Andrea Cavazzoni, Piergiorgio Petronini, Claudio Mucchino, Anna Maria Cantoni, Fabio Leonardi, Luigi Ventura, Stefano Barbieri, Paolo Colombo, Antonella Fusari, Paolo Carbognani, Michele Rusca, Fabio Sonvico
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S207-S220
.
Epidemiology of malignant mesothelioma in Italy: surveillance systems, territorial clusters and occupations involved
Alessandro Marinaccio, Alessandra Binazzi, Michela Bonafede, Davide Di Marzio, Alberto Scarselli, Regional Operating Centres
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S221-S227
.
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: an observational study on outcome and microcirculatory changes
Luca Luzzi, Federico Franchi, Annarita Dapoto, Marco Ghisalberti, Roberto Corzani, Daniele Marrelli, Luca Marchetti, Piero Paladini, Sabino Scolletta
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S228-S236
.

Review Article

Exposure to asbestos: past, present and future
Enrico Pira, Francesca Donato, Luisa Maida, Gianluigi Discalzi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S237-S245
.
The genetic susceptibility in the development of malignant pleural mesothelioma
Ombretta Melaiu, Federica Gemignani, Stefano Landi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S246-S252
.
Clinical diagnosis of malignant pleural mesothelioma
Andrea Bianco, Tullio Valente, Maria Luisa De Rimini, Giacomo Sica, Alfonso Fiorelli
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S253-S261
.
Imaging of malignant pleural mesothelioma: it is possible a screening or early diagnosis program?—a systematic review about the use of screening programs in a population of asbestos exposed workers
Fabio Falaschi, Chiara Romei, Sara Fiorini, Marco Lucchi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S262-S268
.
Endoscopic diagnosis and management of pleural effusion in malignant pleural mesothelioma
Paolo Ceruti, Sara Lonni, Francesca Baglivo, Giampietro Marchetti
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S269-S275
.
The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review
Greta Alì, Rossella Bruno, Gabriella Fontanini
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S276-S284
.
Surgery for malignant pleural mesothelioma: an international guidelines review
Sara Ricciardi, Giuseppe Cardillo, Carmelina Cristina Zirafa, Francesco Carleo, Francesco Facciolo, Gabriella Fontanini, Luciano Mutti, Franca Melfi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S285-S292
.
The role of intracavitary therapies in the treatment of malignant pleural mesothelioma
Pietro Bertoglio, Vittorio Aprile, Marcello Carlo Ambrogi, Alfredo Mussi, Marco Lucchi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S293-S297
.
Diaphragmatic and pericardial reconstruction after surgery for malignant pleural mesothelioma
Piergiorgio Solli, Jury Brandolini, Alessandro Pardolesi, Marco Nardini, Nicola Lacava, Sergio Forti Parri, Kenji Kawamukai, Barbara Bonfanti, Luca Bertolaccini
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S298-S303
.
Chemotherapy treatment in malignant pleural mesothelioma: a difficult history
Marika Cinausero, Karim Rihawi, Francesca Sperandi, Barbara Melotti, Andrea Ardizzoni
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S304-S310
.
Target therapy: new drugs or new combinations of drugs in malignant pleural mesothelioma
Paolo A. Zucali
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S311-S321
.
New horizons from immunotherapy in malignant pleural mesothelioma
Luana Calabrò, Giulia Rossi, Michele Maio
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S322-S332
.
Medical treatment of malignant pleural mesothelioma relapses
Iacopo Petrini, Maurizio Lucchesi, Gianfranco Puppo, Antonio Chella
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S333-S341
.
Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review
Rossella Bruno, Greta Alì, Gabriella Fontanini
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S342-S352
.
Serum mesothelin and other biomarkers: what have we learned in the last decade?
Alfonso Cristaudo, Alessandra Bonotti, Giovanni Guglielmi, Poupak Fallahi, Rudy Foddis
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S353-S359
.
Biomarkers in the prevention and follow-up of workers exposed to asbestos
Rudy Foddis, Alessandra Bonotti, Stefano Landi, Poupak Fallahi, Giovanni Guglielmi, Alfonso Cristaudo
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S360-S368
.
Overexpressed genes in malignant pleural mesothelioma: implications in clinical management
Elisa Barone, Federica Gemignani, Stefano Landi
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S369-S382
.

Perspective

Health surveillance for former asbestos exposed worker: a specific programme developed in an Italian region
Elisabetta Chellini, Francesca Battisti, Alfonso Cristaudo, Pietro Sartorelli, Piergiuseppe Calà
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S383-S389
.

Editorial

Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice
Pier Luigi Filosso, Francesco Guerrera, Paolo Olivo Lausi, Roberto Giobbe, Paraskevas Lyberis, Enrico Ruffini, Alberto Oliaro
Journal of Thoracic Disease  
2018;
10
(Suppl 2)
:S390-S394
.

Disclosure:

The supplement “Present and Future of the Malignant Pleural Mesothelioma” was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding. Marco Lucchi, Alfredo Mussi, Luca Bertolaccini and Roberto Crisci served as the unpaid Guest Editors for the supplement.